e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Asthma and lung immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma
Vibeke Backer (Copenhagen, Denmark), Vibeke Backer, Kathrine Baines, Heather Powell, Celeste Porsbjerg, Peter Gibson
Source:
International Congress 2015 – Asthma and lung immunology
Session:
Asthma and lung immunology
Session type:
Thematic Poster Session
Number:
1084
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vibeke Backer (Copenhagen, Denmark), Vibeke Backer, Kathrine Baines, Heather Powell, Celeste Porsbjerg, Peter Gibson. LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma. Eur Respir J 2015; 46: Suppl. 59, 1084
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Low lung volume is associated with visceral adipose tissue inflammation
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
LATE-BREAKING ABSTRACT: The heterogeneity of systemic inflammation in bronchiectasis
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Characterisation of adipose tissue macrophage phenotypes in obese asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice.
Source: International Congress 2014 – E-cigarettes in different populations
Year: 2014
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Chymase-positive mast cells represent a major source for IL-17A in airway inflammation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Inhibitors of apoptosis proteins in asthmatic airway inflammation
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
MIP-1β is associated with eosinophilic airway inflammation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept